No Matches Found
No Matches Found
No Matches Found
Sampre Nutritions Ltd
Sampre Nutritions Ltd Valuation Shifts Signal Renewed Price Attractiveness
Sampre Nutritions Ltd has witnessed a significant shift in its valuation parameters, moving from a fair to a very attractive rating, despite recent share price declines. This article analyses the evolving price-to-earnings (P/E) and price-to-book value (P/BV) ratios in the context of historical trends, peer comparisons, and broader market performance, providing a comprehensive view for investors assessing the stock’s current appeal.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Sampre Nutritions Ltd Valuation Shifts Signal Changing Market Perception
Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has witnessed a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. Despite a recent upgrade in its valuation outlook, the company continues to face challenges reflected in its negative return on capital employed and equity, prompting a cautious stance from analysts.
Sampre Nutritions Q4 FY26: Strong Revenue Surge Masks Underlying Profitability Concerns
Sampre Nutritions Limited, a micro-cap FMCG manufacturer specialising in sugar confectionery products, reported a dramatic turnaround in Q4 FY26 (Mar'26), posting consolidated net profit of ₹1.35 crores compared to a loss of ₹7.35 crores in the corresponding quarter last year. Despite the 104.33% quarter-on-quarter revenue surge to ₹15.10 crores, the company's stock has plummeted 69.08% from its 52-week high of ₹42.33, currently trading at ₹13.09 with a market capitalisation of ₹113.00 crores.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Mar 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Mar 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 May 2026, providing investors with the latest insights into its performance and outlook.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 May 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with the latest insights into its performance and outlook.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Sampre Nutritions Ltd Falls 1.22%: Death Cross and Downgrade Signal Rising Risks
Sampre Nutritions Ltd experienced a challenging week ending 20 March 2026, with its share price declining 1.22% to close at Rs.21.84, underperforming the Sensex which fell 0.28%. The week was marked by a significant technical development—the formation of a Death Cross—alongside a downgrade to a Strong Sell rating by MarketsMOJO, reflecting mounting concerns over the stock’s medium-term outlook amid fundamental weaknesses and volatile price action.
Sampre Nutritions Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns
Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has seen its investment rating downgraded from Sell to Strong Sell as of 19 Mar 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial fundamentals, and valuation concerns despite recent positive quarterly results and impressive stock returns over the past year.
Sampre Nutritions Ltd Forms Death Cross, Signalling Potential Bearish Trend
Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has recently formed a Death Cross as its 50-day moving average (DMA) crossed below the 200 DMA, signalling a potential shift towards a bearish trend. This technical development, coupled with deteriorating momentum indicators and a downgrade in its Mojo Grade to Strong Sell, raises concerns about the stock's near-term outlook despite its impressive long-term performance.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
When is the next results date for Sampre Nutritions Ltd?
The next results date for Sampre Nutritions Ltd is 13 February 2026.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
